# Notable Labs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/notable-labs

- Industry: Biotechnology
- Headquarters: Foster City, US
- Website: www.notablelabs.com
- Total disclosed funding: $55M
- Latest round: Series B (Jun 28, 2019)
- Investors on record: 5

## About

Founded in 2014 and based in California, US, Notable Labs, Inc., operates as a biotechnology company that provides personalized oncology lab testing services for patients with blood cancers. In June 2022, Notable Labs Inc., raised USD 10.06 million in venture funding from unspecified investors. As of 2023, the company is led by its CEO, Thomas A. Bock, and has partnered with Texas Children’s Hospital, Princess Margaret Cancer Centre, Seattle Children’s Hospital, and many more health institutes and hospitals.

Notable offers a predictive technology platform used for the development of clinical therapies for cancer treatments. The company’s platform utilizes automation, software, laboratory science, and data science to generate a data repository for hematologic and other malignancies on its compound sensitivity platform, which helps to identify and accelerate therapeutic candidates.

## Funding rounds

- Series B, Jun 28, 2019, $40M — Industry Ventures, B Capital, LifeForce Capital
- Series A, Aug 16, 2017, $15M — Builders VC
- Seed, Mar 1, 2015 — First Round Capital

## Investors

- First Round Capital (https://capitalatlas.ai/funds/first-round-capital) — Seed
- Builders VC (https://capitalatlas.ai/funds/builders-vc) — Series A
- Industry Ventures (https://capitalatlas.ai/funds/industry-ventures) — Series B
- B Capital (https://capitalatlas.ai/funds/b-capital) — Series B
- LifeForce Capital (https://capitalatlas.ai/funds/lifeforce-capital) — Series B